PRISM MarketView Features Q&A with President and CEO David Elsley: Cardiol Therapeutics Enters Phase 3 Clinical Trial for CardiolRxâ„¢ Addressing Patients with Recurrent Pericarditis Dec 19, 2024 08:30AM
CEO Presenting on the Emerging Growth Conference on May 25 Register Now May 24, 2022 07:00AM